Sex-oriented perspectives in immunopharmacology.

Cignarella, Andrea; Vegeto, Elisabetta; Bolego, Chiara; Trabace, Luigia; Conti, Lucia; Ortona, Elena

Cignarella, Andrea; Vegeto, Elisabetta; Bolego, Chiara; Trabace, Luigia; Conti, Lucia; Ortona, Elena.

Afiliación

Cignarella A; Department of Medicine, University of Padova, Padova, Italy. Electronic address: andrea.cignarella@unipd.it.
Vegeto E; Department of Pharmaceutical Sciences, University of Milan, Milan, Italy.
Bolego C; Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Padova, Italy.
Trabace L; Department of Clinical and Experimental Medicine, University of Foggia, Foggia, Italy.
Conti L; Center for Gender-Specific Medicine, Istituto Superiore di Sanità, Rome, Italy.
Ortona E; Center for Gender-Specific Medicine, Istituto Superiore di Sanità, Rome, Italy.

Pharmacol Res ; 197: 106956, 2023 Nov.

Article en En | MEDLINE | ID: mdl-37820857

Asunto(s)

Antígeno B7-H1; Neoplasias; Humanos; Masculino; Femenino; Receptor de Muerte Celular Programada 1; Neoplasias/tratamiento farmacológico; Inhibidores de Puntos de Control Inmunológico/uso terapéutico; Autoinmunidad

Palabras clave

Immune checkpoint inhibitors; Immune system modulating agents; Sex and gender pharmacology; Teplizumab: TNF inhibitors

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Antígeno B7-H1 / Neoplasias Tipo de estudio: Guideline Límite: Female / Humans / Male Idioma: En Revista: Pharmacol Res Asunto de la revista: FARMACOLOGIA Año: 2023 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google